US cracks down on investors with Russian, Chinese links

Israel-US
Israel-US

Enhanced regulations governing the Committee on Foreign Investment in the US (CFIUS) go into effect today. How does this affect Israeli investors?

On February 13, 2020, enhanced regulations governing the Committee on Foreign Investment in the United States (CFIUS) will go into effect that increase its authority to review and approve proposed foreign investments in US businesses or real estate. CFIUS has broad jurisdiction and in practice has recently subjected transactions involving Chinese or Russian investors or acquirers to heightened scrutiny to counter perceived threats from those countries. Israeli investors or companies should be aware that CFIUS may encumber their future US investments, especially if those Israeli parties accept funding from or maintain relevant affiliations with Chinese or Russian persons. Israeli financial and strategic investors in US businesses or real estate and joint ventures should consider CFIUS implications early in securing funding and structuring transactions. CFIUS due diligence would especially be relevant in instances where the US business is involved with critical technology, critical infrastructure, or sensitive data or if the US real estate is located close to sensitive US government or other sites as prescribed in the regulations.

CFIUS is empowered to review foreign investments in US businesses (including US operations of foreign businesses) that could result in foreign control of the US business or provide foreign persons with certain non-controlling rights such as access to material nonpublic technical information, board membership or observer rights, or substantive decision-making authority regarding certain topics. CFIUS typically either approves the transaction or imposes conditions to mitigate national security risk.

Although CFIUS has long had authority to unwind, block, or mitigate the risk posed by a transaction where a foreign person gains control of a US business, the new regulations broaden CFIUS’s jurisdiction over certain non-controlling investments and require mandatory filings for some transactions. Israeli investors should be cautious that even minor investments in US businesses may require filing with CFIUS or otherwise face significant penalties, including fines up to the value of the transaction or divestiture.

CFIUS filings are currently mandatory for certain types of investments in US critical technology companies involved with relevant industries listed in the CFIUS regulations. As of February 13th, mandatory filings will also apply with respect to certain investments in a US business involved with critical technology, critical infrastructure, or sensitive data if a foreign government has a "substantial interest" in the investor. These mandatory filing requirements highlight CFIUS’s key national security concerns, which range from traditional threats posed by foreign control or access to defense, telecommunications, or energy locations and infrastructure, to more modern threats posed by aggregated data about US citizens or transfer of sensitive technology.

CFIUS may review covered transactions at any time - including those already consummated - and actively seeks out transactions about which it was not notified. This incentivizes parties to voluntarily undergo CFIUS review in exchange for eliminating the risk of future CFIUS review and mitigation. This future CFIUS risk for completed transactions should be a key consideration for private equity and other repeat investors.

The new rules also contain some exemptions. Investment funds with US general partner(s) and limits on the information and control rights of foreign limited partners may avoid CFIUS review for non-controlling investments. The new regulations also designate Australia, Canada, and the United Kingdom as "excepted foreign states," providing qualified investors from those countries with a similar exemption.

Published by Globes, Israel business news - en.globes.co.il - on February 13, 2020

© Copyright of Globes Publisher Itonut (1983) Ltd. 2020

Dr. R  credit: Jonathan Bloom Wounded in his tank, now R develops protection systems

"I was close to death, but it sharpened my awareness of the products we develop for the IDF."

Ella Kenan  credit: Yossi Cohen A fighter of fake news about Israel

Ella Kenan saw online denial of October 7 happening straightaway. "I realized we had 24 hours, or we were doomed"

Liron Horshi credit: Jonathan Bloom Wiz's talent manager nurtures $1b workforce

Wiz's $32 billion sale to Google was rooted in the cloud security product if offers but could not have been achieved without the quality of its employees built by human resources chief Liron Horshi.

Yoav Shoham  credit: Eyal Izhar Yoav Shoham: AI isn't too smart, it's too dumb

AI21 Labs founder and CEO Prof. Yoav Shoham talks to "Globes" about dubious doomsday predictions, what should really concern us, and what could make Israel a global AI leader.

Insightec COO and general manager Eyal Zadicario credit: Ness Productions After 25 years of losses Insightec focuses on profit

Insightec COO and general manager Eyal Zadicario tells "Globes" about himself and the Israeli ultrasound company's long battle to change the medical world.

Amit Shaked credit: Tomer Lesher Driven to succeed but balancing ambition with wellbeing

At just 14, cybersecurity company Rubrik VP Amit Shaked began a B.Sc. in Computer Science and Math and mapped out his entire future, which included IDF service in the 8200 unit, and an inevitable huge startup exit.

Dr. Ola Gutzeit  credit: Ketty Hakim The doctor breaking new ground in fertility

"We know nothing about the female reproductive system," says Dr. Ola Gutzeit of Rambam Hospital. She seeks to change that, and hence change IVF for the better.

Google CEO Sundar Pichai  crediit: Shutterstock Why Google is paying so much for Wiz

Lagging its competitors in cloud and AI, and facing challenges to its core advertising business, Google could be looking to spend its way out of trouble.

Prof. Douglas Irwin  credit: Inbal Marmari "We will all be poorer"

Prof. Douglas Irwin, an expert on international trade, talks to "Globes" about the impact of President Trump's tariffs policy, and what Israel can do about it.

Rooftop solar panels credit: Shutterstock Does it pay for homes to install rooftop solar panels?

As the Israeli government steps up efforts to encourage homeowners to produce their own electricity from rooftop panels, "Globes" investigates the advantages and pitfalls.

UnitedHealth founder Richard Burke credit: Ken Easley UnitedHealth founder: US health system is broken

In an exclusive interview Richard Burke talks about the murder of the company's CEO, Donald Trump, his love for Israel, and investment in Israeli startup Korro AI.

Left to right: Karin Goldberg, Einav Laser, Dr. Arseniy Lobov, Dr. Paola Antonello, Dr. Merav Shmueli, and Prof. Yifat Merbl (center in black)  credit: Weizmann Institute Israeli scientists' discovery could lead to new antibiotics

Prof. Yifat Merbl of the Weizmann Institute and her team have found a natural source of anti-microbial substances in the "garbage can" of human cells.

Peter Kash credit: personal photograph Peter Kash confident about cancer cure breakthrough

In Israel for IATI's MIXiii International Life Science and Health-Tech week, the US investor talks about his life science portfolio and the opportunities Israel must seize.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018